Phoenix Biotech Acquisition Corp.
PBAX · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $3,327 | $476 | $1,099 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $387 | $225 | $263 |
| Total Curr. Assets | $3,714 | $42,367 | $1,361 |
| Property Plant & Equip (Net) | $1,993 | $0 | $0 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $178,500 |
| Tax Assets | $0 | $0 | $70 |
| Other NC Assets | $500 | $0 | $148 |
| Total NC Assets | $2,493 | $0 | $178,717 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $6,207 | $42,367 | $180,078 |
| Liabilities | – | – | – |
| Payables | $4,507 | $1,653 | $14 |
| Short-Term Debt | $876 | $650 | $0 |
| Tax Payable | $0 | $599 | $80 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $2,019 | $27,846 | $3 |
| Total Curr. Liab. | $7,402 | $30,748 | $98 |
| LT Debt | $699 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $0 | $9,150 | $0 |
| Total NC Liab. | $699 | $9,150 | $9,150 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 |
| Total Liabilities | $8,101 | $39,898 | $9,248 |
| Equity | – | – | – |
| Pref Stock | $1,250 | $0 | $0 |
| Common Stock | $86 | $13,225 | $178,501 |
| Retained Earnings | -$70,918 | -$10,756 | -$7,670 |
| AOCI | $0 | $0 | $178,501 |
| Other Equity | $68,938 | $0 | $0 |
| Total Equity | -$1,895 | $2,469 | $170,830 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6,207 | $42,367 | $180,078 |
| Net Debt | -$1,752 | $174 | -$1,099 |